Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2026-05-17 @ 1:31 PM
Study NCT ID:
NCT02977494
Status:
COMPLETED
Last Update Posted:
2022-05-31
First Post:
2016-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: